About Vyriad
Vyriad engineers targeted virus platforms that bring durable in vivo gene therapies, genome editing, and oncolytic virotherapies to patients.
Sectors & Market Categories
Company Details
Corporate & Operational Profile
Primary Industry
Biotech & Healthcare
Funding Stage
Series-B
Global Headquarters
Rochester, United States
Tracked Since
Nov 6, 2026
Web & Domain Identity
Official Website
vyriad.com
Domain Registered Date
Undisclosed
Social & Network Presence
X / Twitter Profile
@VyriadMN
(42 followers)
LinkedIn Corporate
Company Profile
Company Milestones & Timeline
- Capital Raise
Raised $25,000,000 · Series-B
Backed by Harry H. Stine
- Capital Raise
Raised undisclosed · Series-B
fundraisingfox.com
Investors & Backers
Harry H. Stine
Lead
Mayo Clinic
Mirae Asset Capital
Regeneron Ventures
Southeast Minnesota Capital Fund
Funding History
Series-B equity
· Jan 2, 2026
Round backers: Harry H. Stine
$25,000,000 fundraisingfox.com
Series-B equity
· May 18, 2022
undisclosed fundraisingfox.com
Founders & Leadership
Press Coverage & Sources
Recently Funded Biotech & Healthcare Startups
View allTesorai
tesorai.com
Seed Nov 2026
Commit Biologics
commitbio.com
Seed Aarhus · Nov 2026
Human Biome
human-biome.com
Series-A Warsaw · Nov 2026
MedInTech
medintech.co.kr
Series-B Seoul · Nov 2026
Ace Padel
acepadel.com
Seed Bradenton, United States · Nov 2026
Mentix
mentix.world
Pre-Seed London, United Kingdom · Nov 2026